Melinta Therapeutics, Inc. Just Reported Earnings, And Analysts Cut Their Target Price

One of the biggest stories of last week was how Melinta Therapeutics, Inc. (NASDAQ:MLNT) shares plunged 36% in the… …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.